Trials / Completed
CompletedNCT02014129
A Study of LY2835219 in Japanese Participants With Advanced Cancer
A Phase 1 Study of LY2835219 in Japanese Patients With Advanced Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate safety and side effects of LY2835219 in Japanese participants with advanced cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY2835219 | Administered orally |
Timeline
- Start date
- 2013-12-18
- Primary completion
- 2015-04-01
- Completion
- 2019-08-21
- First posted
- 2013-12-18
- Last updated
- 2020-08-24
- Results posted
- 2020-08-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02014129. Inclusion in this directory is not an endorsement.